EUVIMEDEUVIMED entdecken
Crossref

Induction of the Inflammasome by the SARS‐CoV‐2 Accessory Protein ORF9b, Abrogated by Small‐Molecule ORF9b Homodimerization Inhibitors

Erika Zodda iD, Mònica Pons, Natàlia DeMoya-Valenzuela iD, Cristina Calvo-González iD, Cristina Benítez-Rodríguez iD, Blanca D López-Ayllón iD, Achraf Hibot, Alice Zuin iD, Bernat Crosas iD, Marta Cascante iD, María Montoya iD, María D Pujol iD und 2 weitere

Journal of Medical Virology · 2025-02 · 97 (2)

DOI: 10.1002/jmv.70145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 04.02.2025. Verfasst von Erika Zodda und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cell Signaling and Cancer, Barcelona Institute for Molecular Biology, Spanish National Scientific Research Council (IBMB-CSIC), Barcelo…. Hauptthemen laut MEDLINE: Inflammasomes, SARS-CoV-2, Viral Regulatory and Accessory Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: This work was funded by the Spanish National Research Council (CSIC, project numbers CSIC-COV19-006, CSIC-COV-19-201, CSIC-COV-19-117, SGL2103019, SGL2103015,….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viral accessory proteins play critical roles in viral escape from host innate immune responses and in viral inflammatory pathogenesis. Here we show that the SARS‐CoV‐2 accessory protein, ORF9b, but not other SARS‐CoV‐2 accessory proteins (ORF3a, ORF3b, ORF6, ORF7, ORF8, ORF9c, and ORF10), strongly activates inflammasome‐dependent caspase‐1 in A549 lung carcinoma cells and THP‐1 monocyte‐macrophage cells. Exposure to lipopolysaccharide (LPS) and ATP additively enhanced the activation of caspase‐1 by ORF9b, suggesting that ORF9b and LPS follow parallel pathways in the activation of the inflammasome and caspase‐1. Following rational in silico approaches, we have designed small molecules capable of inhibiting the homodimerization of ORF9b, which experimentally inhibited ORF9b‐ORF9b homotypic interactions, caused mitochondrial eviction of ORF9b, inhibited ORF9b‐induced activation of caspase‐1 in A549 and THP‐1 cells, cytokine release in THP‐1 cells, and restored type I interferon (IFN‐I) signaling suppressed by ORF9b in both cell models. These small molecules are first‐in‐class compounds targeting a viral accessory protein critical for viral‐induced exacerbated inflammation and escape from innate immune responses, with the potential of mitigating the severe immunopathogenic damage induced by highly pathogenic coronaviruses and restoring antiviral innate immune responses curtailed by viral infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammasomesSARS-CoV-2Viral Regulatory and Accessory ProteinsHumansA549 CellsCaspase 1THP-1 CellsProtein MultimerizationCOVID-19LipopolysaccharidesViroporin ProteinsSmall Molecule Libraries

Stichwörter der Autor:innen

ORF9bSARS‐CoV‐2accessory proteinsdrug discoveryinflammasomevirtual screening

Substanzen

InflammasomesCaspase 1Viral Regulatory and Accessory ProteinsLipopolysaccharidesViroporin ProteinsSmall Molecule Libraries

Autor:innen und Institutionen

  • Laboratory of Cell Signaling and Cancer, Barcelona Institute for Molecular Biology, Spanish National Scientific Research Council (IBMB-CSIC), Barcelona, Spain.
  • Department of Materials Science and Physical Chemistry, University of Barcelona, Barcelona, Spain.
  • Theoretical and Computational Chemistry Research Institute (IQTCUB), Barcelona, Spain.
  • Viral immunology Lab, Molecular Biomedicine Department, Margarita Salas Center for Biological Research (CIB-CSIC), Madrid, Spain.
  • Laboratory of Pharmaceutical Chemistry, School of Pharmacy, University of Barcelona, Barcelona, Spain.
  • Regulation of the Proteasome Laboratory, Barcelona Institute for Molecular Biology, Spanish National Scientific Research Council (IBMB-CSIC), Barcelona, Spain.

ORCID-Profile: Erika Zodda, Natàlia DeMoya-Valenzuela, Cristina Calvo-González, Cristina Benítez-Rodríguez, Blanca D López-Ayllón, Alice Zuin, Bernat Crosas, Marta Cascante, María Montoya, María D Pujol, Jaime Rubio-Martínez, Timothy M Thomson

Förderung

  • This work was funded by the Spanish National Research Council (CSIC, project numbers CSIC-COV19-006, CSIC-COV-19-201, CSIC-COV-19-117, SGL2103019, SGL2103015,…

Zitieren

APA

Zodda, E., Pons, M., DeMoya-Valenzuela, N., Calvo-González, C., Benítez-Rodríguez, C., López-Ayllón, B. D., Hibot, A., Zuin, A., Crosas, B., Cascante, M., Montoya, M., Pujol, M. D., Rubio-Martínez, J., & Thomson, T. M. (2025). Induction of the Inflammasome by the SARS‐CoV‐2 Accessory Protein ORF9b, Abrogated by Small‐Molecule ORF9b Homodimerization Inhibitors. Journal of Medical Virology, 97(2). https://doi.org/10.1002/jmv.70145

Vancouver

Zodda E, Pons M, DeMoya-Valenzuela N, Calvo-González C, Benítez-Rodríguez C, López-Ayllón BD, et al. Induction of the Inflammasome by the SARS‐CoV‐2 Accessory Protein ORF9b, Abrogated by Small‐Molecule ORF9b Homodimerization Inhibitors. Journal of Medical Virology. 2025;97(2). doi:10.1002/jmv.70145

BibTeX
@article{Zodda2025,
  author = {Zodda, Erika and Pons, Mònica and DeMoya-Valenzuela, Natàlia and Calvo-González, Cristina and Benítez-Rodríguez, Cristina and López-Ayllón, Blanca D and Hibot, Achraf and Zuin, Alice and Crosas, Bernat and Cascante, Marta and Montoya, María and Pujol, María D and Rubio-Martínez, Jaime and Thomson, Timothy M},
  title = {Induction of the Inflammasome by the SARS‐CoV‐2 Accessory Protein ORF9b, Abrogated by Small‐Molecule ORF9b Homodimerization Inhibitors},
  journal = {Journal of Medical Virology},
  year = {2025},
  volume = {97},
  number = {2},
  doi = {10.1002/jmv.70145}
}
Kostenlos starten →